Optical transillumination spectroscopy to quantify parenchymal tissue density: An indicator for breast cancer risk

British Journal of Radiology

Volumn 78, Issue 935, 2005, Pages 1009-1017

  Simick, M K ^a,b,d   Lilge, L ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d CREDIT VALLEY HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE; ADULT; ARTICLE; BREAST CANCER; BREAST EXAMINATION; CANCER RISK; CELL DENSITY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC IMAGING; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NEAR INFRARED SPECTROSCOPY; PARENCHYMA; PATIENT MONITORING; PREDICTION; REGRESSION ANALYSIS; TISSUE DIFFERENTIATION;

ADULT; AGED; BREAST; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; FEASIBILITY STUDIES; FEMALE; HUMANS; LEAST-SQUARES ANALYSIS; MAMMOGRAPHY; MENOPAUSE; MIDDLE AGED; OPTICS; RISK ASSESSMENT; SCATTERING, RADIATION; SPECTRUM ANALYSIS; TRANSILLUMINATION;

EID: 28044461284     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/14696165     Document Type: Article

References (37)

1. National Cancer Institute of Canada. Canadian Cancer Statistics 2001, Toronto, Canada.
2. National Cancer Institute of Canada. Canadian Cancer Statistics 2000, Toronto, Canada.
3. Paci E, Duffy S, Rosseli di Truco M. 11.3 Mammographic screening: from the scientific evidence to practice. In: The Oxford textbook of oncology. Oxford; New York: Oxford University Press, 2000.
4. NF Boyd. Chapter 11.1 The epidemiology of breast cancer. In: The Oxford textbook of oncology. Oxford; New York: Oxford University Press, 2000.
5. Janocko, LE, Brown KA, Smith, CA, Gu LP, Pollice AA, Singh SG, et al. Distinctive patterns of Her-2/Neu, c-myc and Cyclin D1 gene amplification by fluorescence in situ hybridization in primary human breast cancers. Cytometry 2001;46:136-49.
6. El-Bastawissi, AY, White E, Mandelson MT, Taplin SH. Reproductive and hormonal factors associated with mammographic breast density by age (United States). Cancer Causes Control 2000;11:955-63.
7. Ziv E, Shepherd J, Smith-Bindman R, Kerlikowske K. Mammographic breast density and family history of breast cancer. JNCI 2003;95:556-8.
8. Wenten M, Gilliland FD, Baumgartner K, Samet JM. Associations of weight, weight change, and body mass with breast cancer risk in Hispanic and non-Hispanic white women. Ann Epidemiol 2002;12:435-44.
9. Hilakivi-Clarke L. Estrogens, BRCA1 and breast cancer. Cancer Research 2000;60:4993-5001.
10. Byng J. "Mammographic densities and risk of breast cancer" PhD Thesis, University of Toronto, Canada, 2000.
11. Boyd NF, Lockwood GA, Byng J, Tritchler DL, Yaffe M. Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998;7:1133-44.
12. Wolfe J. Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer 1976;37:2486-92.
13. Wolfe JN. Breast patterns as an index of risk for developing breast cancer. AJR Am J Roentgenol 1976;126:1130-7.
14. Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, et al. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. JNCI 1995;87:670-5.
15. Byrne C, Schairer C, Wolfe C, Parkh N, Salane N, Brinton LA, et al. Mammographic features and breast cancer risk: effects with time, age, and menopause status. JNCI 1995;87:1622-9.
16. Boyd NF, Greenburg C, Lockwood G, Little L, Martin L, Byng J, et al. Effects at two years of a low-fat, high carbohydrate diet on radiologic features of the breast: results from a randomized trial. JNCI 1997;89:488-96.
17. Enger SM, Bernstein L. Exercise activity, body size and premenopausal breast cancer survival. Br J Cancer 2004;90:2138-41.
18. Kreienberg R, Kafka A. From alcohol abstinence to total surgery. Preventive strategies in breast carcinoma. Fortschr Med 2003;145:32-3.
19. Thornton H. Anastrozole as a preventive agent in breast cancer. Lancet 2003;361:1911-2.
20. Harper-Wynne C, Ross G, Sacks N, Salter J, Nasiri N, Iqbal J, et al. Effects of the aromatase inhibitor letrozole on normal breast epithelial cell proliferation and metabolic indices in postmenopausal women: a pilot study for breast cancer prevention. Cancer Epidemiol Biomarkers Prev 2002;11:614-21.
21. Byng JY, Boyd NF, Fishell E, Jong RA, Yaffe MJ. Automated analysis of mammographic densities. Phys Med Biol 1996;41:909-23.
22. Konez O, Goyal M, Reaven RE. Can Tamoxifen cause a significant mammographic density charge in breast parenchyma? J Clin Imaging 2001;25:303-8.
23. Quaresima V, Matcher SJ, Ferrari M. Identification and quantification of intrinsic optical contrast for near-infrared mammography. Photochem Photobiol 1998;67:4-14.
24. Egan RL, Dolan PD. Optical spectroscopy. Pre-mammography marker. Acta Radiologica 1988;29:497-503.
25. Peters VG, Wyman DR, Patterson MS, Frank GL. Optical properties of normal and diseased human breast tissues in the visible and near infrared. Phys Med Biol 1990;35:1317-34.
26. Simick MK, Jong R, Wilson BC, Lilge L. Non ionizing near infrared radiation transillumination spectroscopy for breast tissue density and breast cancer assessment. JBO 2004;9:794-803.
27. Simick M. "Near infrared transillumination spectroscopy of breast tissue for correlation with mammographic density," Masters Thesis, Department of Medical Biophysics, University of Toronto, 2002.
28. Blyschak K, Simick M, Jong R, Lilge L. Classification of breast tissue density by optical transillumination spectroscopy: optical and physiological effects governing predictive values. Med Phys 2004;31:1398-414.
29. White E, Velentgas P, Mandelson MT, Lehman CD, Elmore JG, Porter P, et al. Variation in mammographic breast density by time in menstrual cycle among, women aged 40-49. JNCI 1998;90:906-10.
30. Haaland DM, Thomas EV. Partial least-squares methods for spectral analysis. 1. Relation to other quantitative calibration methods and the extraction of qualitative information. Anal Chem 1988;60:1193-202.
31. Haaland DM, Thomas EV. Partial least-squares methods for spectral analysis. 2. Application to simulated and glass spectral data. Anal Chem 1988;60:1202-8.
32. Byng JW, Critten JP, Yaffe MJ. Thickness-equalization processing for mammographic images. Radiology 1997;203:564-8.
33. Cubeddu R, D'Andrea C, Pifferi A, Taroni P, Torricelli A, Valentini G. Effects of the menstrual cycle on the red and near-infrared optical properties of the human breast. Photochem PhotoBiol 2000;72:383-91.
34. Cuzick J, Warwick J, Pinney E, Warren RM, Duffy SW. Tamoxifen and breast density in women at increased risk of breast cancer. JNCI 2004;96:621-8.
35. Warren R. Hormones and mammographic breast density. Maturitas 2004;49:67-78.
36. Kaizer L, Fishell EK, Hunt JW, Foster FS, Boyd NF. Ultrasonographically defined parenchymal patterns of the breast: relationship to mammographic patterns and other risk factors for breast cancer. Br J Radiol 1988;61:118-24.
37. Graham SJ, Bronskill MJ, Byng JW, Yaffe MJ, Boyd NF. Quantitative correlation of breast tissue parameters using magnetic resonance and X-ray mammography. Br J Cancer 1996;73:162-8.